Bullfrog AI (BFRG) AI Drug Discover

First off, I’d like to thank my recent new followers for following me on Substack. I started the Substack in early 2023 and I now have 311 followers. Thank you all for your support.

If you have read my articles on pharma companies or follow my X account here ,you know I have been researching stocks involved in the AI (Artificial Intelligence) theme.

I believe we are still early in the theme. Big techs continued and accelerating CapEx into infrastructure supports this as well as Oracle's ORCL two most recent quarters. Companies from agriculture to Walmart are now using AI to drive results.

I’ve been an early adopter of LLMs (Large Language Models) for research and as a search engine. I’ve almost entirely replaced my Google search use by about 80-90%. I have been very open-minded to the positive future uses of these neural nets.

If you are skeptical of AI or already have a strong negative opinion on it, that’s fine. You can rest assured, for the sake of the company analysis in this article, that machine learning and AI have already been around for over a decade in computational biology and the pharmacutical industry and it has only been positive. There are plenty of articles written explaining the uses of AI and machine learning if you are curious about the uses in the pharma industry. One such article is Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs

I just watched a recent interview with Nvidia (NVDA) CEO Jensen Huang. He mentioned the industries he sees most impacted by AI in the near future. One he mentioned was digital biology. Nvidia has already invested directly into clinical biotechnology company Recursion Pharmaceuticals (RXRX). Recursions mission statement is exactly like Bullfrog AI’s (BFRG).

Recursion was founded to harness the power of accelerating technological innovations to improve the efficiency of drug discovery and development. Bullfrog AI has the same technology focused approach to drug discovery.

I knew for sure I was onto something when one of the value stocks I covered on the Substack SomaLogic got bought out by Standard Biotools (LAB) only a few months after my write-up on it. SomaLogic is a protein biomarker discovery and clinical diagnostic company. They have the SomaScan Platform. It is a tool that helps scientists study proteins in a much faster and more detailed way. It lets researchers understand how proteins work and interact with each other.

Bullfrog AI Bullfrog AI (BFRG) calls itself “an emerging digital biopharma company. Using our proprietary AI/ML analytics platform, we aim to improve drug development and clinical trials through identification of high-value data niches and patient subgroups.”

One of the most interesting things about Bullfrog is they truly are on the cutting edge of technology. They have been working with Johns Hopkins Applied Physics Lab since atleast 2017 and also collaborating with George Washington University. Both Johns Hopkins Hospital and University are some of the most renowned institutions in the nation.

In 2017 Bullfrog AI was granted licenses to a data analysis tool from Johns Hopkins. In March of 2023 they were granted additional licenses to two machine learning tools from Johns Hopkins. Their names are Prometheus and Seagull.

They also have a relationship with the Lieber Institute for Brain Development (LIBD). The collaboration between BullFrog AI and LIBD, announced in September 2023, uses the bfLEAP™ platform to mine LIBD’s comprehensive brain data. This data includes transcriptomic, genomic, DNA methylation, cell-line, clinical, and imaging data from over 2,800 brain samples. Early results announced in January 2024 highlighted the ability to stratify brain expression data, revealing biological subtypes within psychiatric disorders.

Some recent developments came for Bullfrog AI just days ago with the prospects of Bullfrogs drug candidate BF-114. There was a publication of new research in the peer-reviewed journal Cell Reports supporting the potential of BF-114 (SPTBN1 siRNA), in treating a range of liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), and hepatocellular carcinoma (HCC). BF-114 is being developed for the treatment of obesity and liver diseases and this research appears to be promising.

They have acquired the rights to a series of preclinical and early clinical drug assets from universities and entered into a strategic collaboration with a world-renowned research institution to create a HSV1 viral therapeutic platform to engineer immunotherapies for colorectal cancer.

They have signed exclusive worldwide license agreements with Johns Hopkins University for a cancer drug that targets glioblastoma (brain cancer), pancreatic cancer, and other cancers. They have also signed an exclusive worldwide license with George Washington University for another cancer drug that targets hepatocellular carcinoma (liver cancer), and other liver diseases.

Business Strategy

One of their business goals is to “rescue” drugs that have failed in phase 3 clinical trials by using their technology to analyze all available data with the goal of designing a precision medicine clinical trial that will have a better chance of being successful. They see this servicable market as a $47 billion market.

The Company has a unique strategy designed to reduce risk and increase the frequency of cash flow. The first part of the strategy is to generate revenues through strategic relationships with biopharma companies. These relationships will be structured as a combination of fees and intellectual property based on the specific scope of the engagement.

In the future, the second part of our strategy involves acquiring the rights to clinical stage drugs, using our bfLEAP technology to design a precision medicine trial, conduct the trial with a partner, and sell the asset. This approach may also apply to earlier phases in the drug development process such as discovery and preclinical.

The company has two main platforms.

The bfLEAP™- an AI/ML platform for analysis of preclinical and/or clinical data. This is how the company describes bfLEAP in their annual report.

"The analytics industry and application of AI in healthcare is growing rapidly. Competition exists along the entire continuum of the drug development process from discovery to commercialization and beyond.

We believe the weakness of the industry is the quality of the data and we believe bfLEAP provides several competitive advantages, that will position the Company for success.

"First, bfLEAP is highly scalable and can process data from small to extremely large complex data sets without the need for additional code being developed. Second, it is adept at processing and analyzing incomplete data and making predictions that we do not believe other technologies are capable of doing.

Finally, bfLEAP has the ability to extract the most important features for analysis out of extremely large complex data sets using unsupervised machine learning algorithms, thereby greatly simplifying complex problems. Since data quality is a problem that exists in the healthcare industry, we see these as major differentiators." -company annual 10-K

The ability to make predictions, find relationships and patterns and anomalies in extremely large complex data sets has been demonstrated by the Applied Physics Lab in other applications and sectors. Finally, the algorithms used by bfLEAP are proprietary and protected, having been developed at Johns Hopkins University Applied Physics Lab.

We believe most of the competitors rely on open-source algorithms and we also believe that we have already demonstrated our superiority via the August 2021 publication in DeepAI.org."

siRNA -for targeting Beta2-spectrin in the treatment of human diseases developed at George Washington University and licensed by the company.

Valuation Bullfrog AI has a market capitalization of $21.2 million. NCAV (net current asset value) is $5.3 mil. The company didn’t have any revenue in the most recent quarter and revenue has been very sporatic. They generated their first revenues in late 2022 from services provided to a pharmaceutical customer. In the third quarter of 2023 they completed their first commercial service contract and recognized revenue in the amount of $65,000.

For the full year in 2022 the company used $911,000 in cash. They said they expect that to increase going forward. As of the last quarter they have $7 million in cash and a very strong current ratio of 9. There is an accumulated deficit of $11.6 million.

I looked up the company address listed in their annual report at 325 Ellington Blvd, Unit 317, Gaithersburg, MD 20878. It's at what appears to be a retail shopping building. There is a UPS store on one side of it and a ZAGG on the other and a sit-down restaurant at the end of the building. There isn't a business marking on their front. Maybe the Google image is old or they just moved. I don't know.

What explains this is they also say all of the company's employees work virtually and they own no properties. Unless I am mistaken of what I am looking at on Google Maps this is unusual to me though. I was expecting to see an office building.

Technical Analysis The technicals are holding as it is on a major support level that goes way back. This last consolidation looks like a bullish flag on that level. The stock is incredibly volatile.

Full Disclosure: I am long shares of BFRG

Spok Holdings (SPOK): Healthcare IT Company With a 9% Dividend Yield

Spok (SPOK) provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. They offer subscriptions to one and two-way messaging services, voicemail, and equipment loss or maintenance protection services. They serve over 2,200 health care facilities and 83% of their revenue is re-occurring in nature. The current market cap is $271 million with the stock price at $13.60 a share.

Valuation and Metrics

The trailing twelve month PE ratio is 8. Price to sales ratio is around 2. I find this to be a compelling valuation in the current market. Free cash flow has been positive since 2019, except for 2021 which was driven by unusually large capex.

The company has been profitable since the second quarter of 2022. In 2019 to 2021 net income was negative. I didn't look at any years before 2019. Return on equity has been trending upward the past few years. The current ROE is 13% for Q2 2023.

Strong Dividend History

From 2018 to 2021 the company payed $.50 in dividends per share. In 2022 the dividend was raised to $1.25 per share.

In the years prior to 2018 the company made a total of $467 million in dividend payments.

The current quarterly payments are $.3125 per share. With the stock at $13.60 a share the dividend yield is 9% well above the risk free rate.

In addition to shareholder friendly dividends the company also has a history of returning value through share repurchases. In 2018 and 2019 they spent a combined $40 million on sharebuybacks.

Industry Long-term Outlook

The prospects for health IT is strong.

Gobal healthcare information system market size was valued at USD 406.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.3% from 2023 to 2030. Rise in healthcare expenditure and advancements in its IT infrastructure are some of the primary drivers boosting the market. High demand for remote patient monitoring is also significantly driving its adoption rate.

source: https://www.grandviewresearch.com/industry-analysis/healthcare-information-system-market

Other sources share similar growth rates. While the company has not experienced rapidly growing sales the industry growth does provide good defensive stability. The nature of the business doesn't require large debt loads and margins are healthy and stable. This lends to the prospect of meeting future dividend payments.

Technical Analysis

The stock price has been uptrending since the summer of 2022. It formed a base and recently broke out to a new 52 week high on earnings.

It has good short-term technicals with a clean bull flag on the daily chart highlighted in red.

If you like this keep it simple analysis be sure to subscribe to my free Substack where I do analysis on deep value stocks trading below net tangible and net current asset value.





Full disclosure: I have no position at the time of writing. I many take a long position in the future.

Undervalued Tech Stocks

The Nasdaq 100 is up 30% so far this year. It's not easy to find large-cap growing tech companies that haven't already seen significant stock accumulation.

I have been scanning the sector regularly to find attractive longer term opportunities. I remember the early 2000's very well and how accelerating revenue growth in E-commerce propelled so many stocks higher and higher.

The demand for computer power to fuel the growth of AI and large language models is here. Whether you believe it is all hype or the next paradigm of computers like me as personal computers were in the 80s and internet was in the 90s AI is getting investment.

Everyone complains that Nvidia(NVDA) is too expensive at 30 times sales. Here is some historical context on what large companies can do in a bull market.

In the 2003-2007 market Baidu (BIDU) had a price to sales ratio of 30 in spring 2010 and share price of $60. It still ran to $145 at its peak in 12' with a P/S of 44! that's a 100% return after it was at 30 times earnings. I'm not saying Nvidia will grow like that but another 25% return doesn't seem impossible.

In 2015 Alibaba BABA had a price to sales of 16 and the stock still went from $80 to $200 in 2018.

I've been looking at a lot of robotics companies, semi's, silicon miners and IT infrastructer stocks large and small. I've been tweeting about many such stocks for a couple months on Twitter. One such stock, STRC I made a substack article on. Subscribe to my Substack here to catch all my newest deep value net-net ideas.

One recent dive I did was Nauticus Robotics (KITT). It is in the ocean sensory robotics business.

-4.8 Current ratio

-+230% to +440% forward revenue growth,

-36% rev growth this current year

-EPS loss narrowing 6 quarters straight

-no dilution

-risk, only 2 customers

Another interesting thing I stumbled on was that Boston Dynamics a world leader in robotics is owned by Hyundai Motor (HYMTF). They bought the company in 2020 for $1 billion. I'm sure the current market value is much higher now in this AI frenzy.

ARB IOT Group ticker symbol (ARBB) an Asia based smart home technology company IPO'd in April of this year. There appears to be no analysts on it so it was hard to find guidance. I did see some very good growth. There was 2,200% revenue growth in a six month period in 2022. Quarterly earnings growth was 158% per Finviz.com. The balance sheet has a 3.9 current ratio. I need to do some more research but it appears it may be below net current asset value too. The float is only 1.2 million.

Another lower float one I found was IBEX (IBEX). Earnings guidance has been steadily raised over the past few months. Earnings are expected to grow 11% next year. The forward PE ratio is 9.6.

Some of my favorite datacenter stocks are Bel Fuse (BELFB), MongoDB (MDB), Vertiv Holdings (VRT) and a cloud company I like is Zscaler (ZS).

I currently own Nvidia through ETFs and am long KITT and STRC. I may buy or sell any of these stocks in the future. Here is an AI generated image of a modern datacenter.

AI Wars Are Beginning In Tech: How To Invest In Artificial Intelligence

Hello loyal readers! Grab a cup of hot coffee or fresh tea. I have a good one for you today!

My goal is to find the best investment opportunities in artificial intelligence and robotics. After researching the technology in-depth I strongly believe this is the best growth industry opportunity to invest in since the 1990's internet boom. We are still early too! I will continue to put my ideas on the blog here, my Substack and my Twitter/X account going forward.



Microsoft recently made a large investment in OpenAI and has already incorporated AI chat technology into it's search engine Bing. We are continuing to see investment as Inflection AI just secured a massive $1.3 billion funding from major investors including Bill Gates.

If you are brand new to AI technology let me give you some quick background on it. Sam Altman and Illya Sutskever used computers to make a "neural network" that was modeled after the human brain. The computers use high powered "GPU's" graphics cards to process the information.

Deep learning has been going on since the early 2000's but it took major breakthroughs in compute to get us to ChatGPT-3 and 4. Previously, the computers were just not powerful enough. Scientists were also not sold on the concept of scaling up neural nets. This all changed in the last 5 years as computer tech advanced. The increased size of the neural nets combined with increased compute brought breakthroughs leading to ChatGPT.

These vast neural nets are called LLM's (large language models). They use NLP (natural language processing) to retrieve info and generate it. So instead of using code to communicate with the computer you can use words. These massive LLM's are being trained on the internet and thousands of books.

If you haven't checked out the future of chat search I recommend going to Bing.com and clicking the chat icon at the top and using the interactive chat bot which utilizes the ChatGPT technology from OpenAI ChatGPT.

Ask Microsoft Copilot to find your results like you would in Google or Safari. It is incredible and free. The difference vs traditional search is you can talk to it like a person and use more detail. Don't be afraid to test it's limits. It's a streamlined chat style search without the ads, unworthy results in Google's top 10, pop-ups, paywalls or wasted time scrolling multiple results pages.

Microsoft and OpenAI are adding things regularly. You can have it write stories, poems or even articles. They now have an AI image creator too. OpenAI is regularly adding features and plug-ins to ChatGPT-4 if you want to pay for the subscription.

I remember the early days of the internet well in the mid and late 90s. The first time I surfed the web it was with Yahoo search at my dads office because we didn't have it at home yet. I am getting the same vibe using AI powered search now.

AI Is Here To Stay

I think some people maybe even Wallstreet are jaded about AI tech from the over-hype of the recent metaverse and web3 and lack of real-world wide scale implementation. Trust me AI and LLM's(Large Language Models) is legitimate and is going to be revolutionary. How revolutionary? I believe AI technology is someday going to be more revolutionary to mankind than the internet, especially if AGI or something like ASI (artificial superintelligence) or any thing near a singularity is reached.

We still are not experts on what goes on in the brain. What exactly would it take to push AI to a level rivaling human creativity? Human innovation only comes from "learning" and experience after all. If we accelerate the learning as resesrchers are doing as I'm writing this how soon could major scientific breakthroughs occur?

It is already creative and solving problems. these models are still the early versions and are being improved. Eventually, from what I am hearing they could take an Albert Einstein, Sir Isaac Newton, and Nicola Tesla bot and have them theorize on advanced physics. This novice version we have with ChatGPT when you use AutoGPT can perform jokes and I'm hearing even a full comedy skit with a hook and final punchline like great comedians do.

Some people are afraid of advancing this technology that has given a massive technological breakthrough already for the average person. It can proof-read writing, fix spelling and grammar and make sentence structure more consice. It can write articles on any subject. It can write a business plan and do web development coding. Think of it like an assistant for your work or hobbies with the entire knowledge of the internet by your side.

There are crucial externalities like potential slowing investment and the overall economy that could slow down the growth of this technology. If things continue as they are going the research I got from using the Bing AI chatbot(now Copilot) paints a very prosperous picture for growth.

Future Growth

"According to Statista, the market for artificial intelligence (AI) is expected to show strong growth in the coming decade. Its value of nearly 100 billion U.S. dollars is expected to grow twentyfold by 2030, up to nearly two trillion U.S. dollars. These figures are regularly being updated by big banks and analysts as the demand for Nvidia GPUs remains robust.

In 2021, worldwide investment into AI companies increased by 115% since 2020, marking the largest year-on-year growth in AI investment for at least two decades. Total AI investment reached $77.5 billion in 2021. The global AI market, valued at 142.3 billion U.S. dollars as of 2023, continues to grow driven by the influx of investments it receives. This is a rapidly growing market, looking to expand from billions to trillions of U.S. dollars in market size in the coming years."

Best AI Stocks To Buy

Google is behind Microsoft right now with AI search. Bing chatbot came to market first. Bard finally came out but isn't competitive on financial searches. Anecdotally, I've seen mixed feedback for Bard. Googles (GOOGL) main revenue segment is search ad revenue. Google has already been struggling with declining growth in many segments and missing earnings estimates the last four quarters. This new consumer technology is a huge loss for them right now. They are losing some searches to Bing every day now. Granted ChatGPT and Bing haven't moved the needle the real threat is there now. Microsoft being first to market may turn out to be a huge advantage as Samsung has been publicly contemplating dropping Google from their devices.

I expect all major tech companies like IBM, Apple(AAPL), Nvidia (NVDA), Google(GOOGL), Microsoft (MSFT), Adobe (ADBE), Nvidia (NVDA), Meta Platforms (META), Amazon(AMZN) among others to develop advanced AI for the consumer. I see all of these companies benefiting.

Many hardware and robotics companies will do well too as the hardware needs to be updated to handle AI The two popular AI ETFs are Robo Global Robotics and Automation Index ticker (ROBO) and Global X Robotics & Artificial Intelligence (BOTZ).These ETFs provide exposure to companies that develop, deploy or benefit from AI. BOTZ is more concentrated and has fewer companies in the holdings. This means it is less diversified than ROBO. That isn't necessarily a bad thing though because it means it has potential to have more price gain or loss.

The newcomer in AI ETFs is Roundhill Generative AI Technology (CHAT) it is an actively-managed fund designed to provide exposure to companies involved in the theme of generative artificial intelligence, and related technologies.

Internet security as an industry will do well in the future as well. As it gets harder to distinquish a bot from a human security will need to be enhanced. Very soon, if not already voice security will become compromised as bots copy our voices perfectly.

Cyber Security ETFs

The safest way to play the future security growth is with ETF's such as First Trust NASDAQ Cybersecurity (CIBR),ETFMG Prime Cyber Security ETF (HACK) or Global X Cybersecurity ETF (BUG). These sport expense ratios well below 1%. BUG has the highest average daily volume. There are other ETF's but the daily volume is much lower. It is not uncommon for specialized ETF's to fail to deliver because of declining low volume.

Entertainment Will Boom

I suspect as many creative and coding jobs become replaced by machine learning the entertainment and movie industry will benefit greatly two-fold. Firstly, they will be bringing amazing new visual and creative masterpieces to movies and various forms of entertainment. GPT is already creating comedy sets by comedians that have passed. Large movie companies will improve their margins and have bigger profits.

Many people including myself believe a recession of varying magnitudes could arrive shortly. This is not necessarilly a bad thing for movies overall. During the Great Depression, with the advent of new and impressive film technology, people escaped their daily lives by paying for entertainment. Even though unemployment was high people would pay to see the new technological advances in film at the time.

The 1930s are considered the golden era of Hollywood cinema. During this time, the movie industry thrived. Technological advances such as color and sound made movies truly extravagant. The breakthrough of synchronized sound occurred at the end of the 1920s and that of full color motion picture film in the 1930s. Two companies I see potentially benefiting greatly are Warner Bros. Discovery, Inc. (WBD), and The Walt Disney Company (DIS). Both are publicly traded on the stock market.

Some Major Tech Companies

Microsoft is currently in the process of acquiring Activision Blizzard (ATVI) making Microsoft the third largest video game company. My hunch is they will be incorporating GPT into video games bringing a new level to interactive gaming. Duckduckgo.com search is even adding A.I. functionality.

Adobe (ADBE) has benefited greatly this year from incorporating AI into their Firefly image creator software. They are one of the leading image generators in terms of realism. They have beaten their earnings estimates every quarter this year and hit record revenue. I see them continuing to see much success.

I highly suspect having lived through the 90's that the long-term leader in this new tech will take time to emerge. I expect they will share market share significantly as I-phone people will use AI on their phones and Google people will use Bing or maybe Google or even another company not yet in our radar. The future will include deep learning A.I. advanced large language models (LLMs) are machine learning models that are very effective at performing language-related tasks such as translation, answering questions, chat and content summarization, as well as content and code making. They distill value from huge data sets and make that “learning” accessible out of the box.

I've also seen LLM's referred to as "life long learning machines" which is essentially what GPT does as it learns from your input and corrections. The feedback all companies can get from customers and clients from generative AI will be great for their marketing and profitablity. We are just in the beginning of seeing the benefits to large and mega companies. Imagine how big the impact will be when most small business owners are using AI in the future.

Final Thoughts

Finally, as far as stocks go I see the most obvious alpha in shorting the companies losing to this technology right now. I am long May Google puts so if the stock falls I see profit. I plan on continuing to long puts as the market is not aware of the changes happening with chatbot search.

It's hard to pick the sole long-term winner with new technology as every other technology breakthrough has shown. Few would have pegged Amazon a lowly book seller as becoming the giant it is as just one example. With this in mind, going the ETF route like ticker BOTZ or CHAT with diversification is the safest bet. Even a Nasdaq 100 fund or Invesco ETF like ticker symbol QQQ is heavily exposed to big tech which are all building AI.

I expect many industries will benefit from this technology becoming acessible to consumers. Right now Microsoft, Google's Bard and Snapchat are battling in the war for large LLM's. More newcomers are popping up rapidly. Now there is Perplexity for Android and conversational HeyPi an AI assistant. These are certainly exciting times.

I also write a free Substack on value stocks. Subscribe here for free value oriented stock ideas. I cover Ben Graham net current asset stocks, net tangible assets and net cash values.

Join Robinhood with my link and we'll both pick our own free stock 🤝

Two Interesting Deep Values

Here we go with the two deep values! I recently ran a screen looking for a particular kind of deep value stock. I was looking for either sub net tangible asset value or net current asset value. I screened out Chinese, semi’s, and biotech as these in my opinion tend to be less reliable as investments in the micro and small-cap space.

One of the more interesting I found was Crimson Wine Group, Ltd. (CWGL). I’ve rarely seen beverage companies below net tangible or NCAV before. A couple good ones that come to mind from years ago were Caribou Coffee and Coffee Holding when they were briefly below net tangible asset value. Caribou Coffee was bought by private equity after I wrote about it. I’ve never seen a wine company near deep value level.

Crimson Wine is currently trading for 59% of net tangible asset value. It is a wine wholesaler and direct to customer. From the most recent SEC EDGAR filings we have net tangible asset value of $221.4 million and market cap of just $133 million. Net current asset value is not far away at $72 million. They haven’t diluted with any recent offerings the past couple years as shares outstanding has been stable and slightly down. Cash has been stable on the balance sheet also. Cash is slightly up over the past couple years.

The company has had a slightly profitable quarter in the last year. The share price has been up and down. The stock had a good run from fall of 2020 to summer 2021 and has been down since. I always like to see a stock price that has had some kind of history of share price appreciation. So many small and micro-cap companies never have any history of stock appreciation so it is always nice to see the market can indeed react to positive performance. The company had positive free cash flow for the trailing 12 months ending Q3 last year of $8 million.

The second stock is Save Foods, Inc. (SVFD). It develops and sells eco-friendly green treatments for the food industry to enhance food safety and shelf life of fresh produce. This one is a small micro-cap with a market cap of $5.3 million. Net current asset value is $6.63 million. They grew revenue a whopping 88% from 2020 to 2021 although there is not an annual net profit in the last three years. Cash has been stable the last three years, however, shares outstanding has been diluted. From the second to third quarter of 2022 share count went from 2.8 million to 4.5 million.

If you liked this article subscribe here to my free Substack here where I cover deep value ideas.



Disclosure: I currently have no position in either of these stocks.

Starting a Substack For Net Current Asset and Deep Value Stocks

I am starting a substack for strictly stock analysis of deep value net-net's and net tangible asset stocks. Here is my Substack. Here are a couple of the most recent deep values I came across from my screening. This is the first round of interesting sub NCAV or net tangible asset value stocks. Screen excludes Chinese, semis, biotech. In millions. These figures and for the ones going forward I will be getting the most recent numbers via the SEC.gov Edgar search database.

CWGL $221.4 NTAV, $72 NCAV with $133 market cap

SVFD $6.63 NCAV $5.3 market cap

AOUT $105.4 NCAV 115.5 NTAV $124 market cap

Coffee Holding JVA Stock Update A Net-Net

I've covered JVA on the blog for many years and shared my honest thoughts on the company. It's been so beaten down in this bear market it is now at .62% of net current asset value. In the past it would bottom out around net tangible asset value. This is one of those rarer cases where a profitable or recently former profitable company becomes a net current asset value stock.

If you are new to deep value the net current asset stocks get their attention because of famous investor Ben Graham who taught Warren Buffett. Net current asset value is a rought liquidation value of the whole company. Of course the true liquidatoin value is usually lower given the inventory and equipment and long-term assets are likely going to fetch less than on the books. They are usually priced so cheap for a reason too.

JVA is now merging with another company. Here is a piece of the SEC filing.

As a condition to the Merger, Pubco shall also acquire all of the issued and outstanding Delta securities from the Sellers in exchange for Pubco Ordinary Shares (the “Exchange” and, collectively with the Merger and the other transactions contemplated by the Merger Agreement, the “Transactions”).

As a result of Transactions, JVA and Delta will each become direct, wholly-owned subsidiaries of Pubco, with JVA stockholders receiving approximately $31.5 million (or 4.79%) worth of Pubco Ordinary Shares (the “Merger Consideration”) and Delta stockholders receiving approximately $625 million (or 95.21%) worth of Pubco Ordinary Shares (the “Exchange Consideration” and collectively with the Merger Consideration, the “Business Combination Consideration”), subject to certain adjustments, at an implied diluted value per share of $5.50.

The Business Combination Consideration may be adjusted if Delta closes certain acquisitions prior to the closing of the Transactions. The Merger Agreement also includes an earn-out to existing stockholders of Delta, consisting of $50 million of additional Pubco Ordinary Shares, which will be released to Delta stockholders if and when Delta achieves $70 million or greater of net income for fiscal year ending 2023. The company they are merging with is private so I don't know anything about them.

Disclosure: I have a position in JVA

Net Current Asset Stocks

As the market continues to be weak I am going to start looking for cheap stocks below net current asset value and net tangible asset value. I just ran a strict scan looking for super discounted assets. This is the first scan I have done in awhile for these as I never thought it would produce much in the most recent bull market. This scan is cherry picked from criteria of price-to-book value of .5 or less, long-term debt to equity less than .3 and return on equity over 1.

The most interesting ones are Vaccitech plc (VACC) with NCAV of $187 million and a market cap of $89 mil. VACC has postive earnings this year with $.22 last quarter and $.42 the quarter before that. Cash has been pretty stable the past year and currently it has $200 mil in cash.

We also have TD Holdings, Inc. (GLG) with $154 mil in NCAV and a market cap of $59 mil. Not as much cash as VACC as the large majority of the current assets are in account receivables. They had a couple recent slightly positive quarters of $.02 earnings per share and $.05. The stock has tried to bottom and has been sideways for months with support around $1.00 a share.

Net Tangible Asset Play AQMS

I found AQMS Aqua Metals in a scan. I calculated rough net tangible asset value at $51.8 mil. The current market cap is $46. Looks like a property fire beat it down quickly but it was down regardless. Balance sheet looks ok. Current ratio is above 1. Seeing revenue guidance from Zacks and Yahoo at $39 mil to $42 mil next year. Up from about $5 mil this year. Earnings misses are narrowing. Seeing 1 or 2 analysts. It is not profitable but it's trying to bottom out here. A clear bull flag off unusual high volume the other day.

Coffee Holding Company (JVA) Deep Value Play

Coffee Holding (JVA) is back around deep value territory after spiking to $7 a share earlier in the year. It's now below $4 a share and I calculated net tangible asset value at $21 million or about $3.77 a share. Net current asset value is not much lower at $18.7 million or $3.35 a share. To me $3.35 to $3.77 roughly is the floor for the stock at such a discount. It's a crazy discount because this company is profitable, growing and in a good industry. I have a small position and will be adding if it continues to dip below NTAV and NCAV.

I Started A Patreon Page

Hello my loyal followers. I just set up a Patreon Page. Become a Patron here!

 If you aren't familiar with it I will tell you a little about it. You can also read about it here. It allows content creators like myself to run a subscription membership. It takes donations that are recurring and billed monthly. That said I will not be changing anything I have been doing or going subscription only at this time. My intent on setting this up is to simply take donations for my continued work on this blog and Twitter. I am very active on my Twitter and continue to post a lot of great alerts. All of my posts and everything will stay public and by donating monthly you will simply be supporting my efforts. At some time in the future I may start cranking out a ton of content on a paid membership only tier that I could post value stocks on like I used to do with net current asset and net tangible asset value stocks and another with trading alerts.

Found a Net-Net

I found a deep value net-net (net current asseets - total liabilities) this week. The company is O2Micro International (OIIM). It has net current asset value of $53.7 million and a market cap around 1.95-2.00 a share of $50 mil. I found it the other day below $2.00 a share with a $50 mil market cap. It's around a $53 mil market cap now which is still a good value given the rich valuations in the overall market. OIIM's past two quarters have been profitable. The chart has good momentum as the stock is near 52 week highs. Disclosure: I have a position

Net Current Asset Stock STLY

Stanley Furniture (STLY) is a well known brand in the furniture industry. With the stock just around a $1.00 a share it's below net current asset value or quick liquidation value. Because a lot of their assets are in furniture inventory this isn't a true "liquidation" value. The margin of safety would peg the stock much lower than net current assets. This is still a compelling net-net. It is a good one I believe if only because it is not a perennial one. Net current asset stocks that suddenly become this cheap that are retail with a good brand name often work out.

Net current assets are 19.2 mil. Market cap is 16 mil. I read the last quarterly and its just not being managed well. They have some apparently short-term supply chain issues. It's a decent net-net especially if they can turn it around any. Things are going poorly at the moment. They have cashed out life insurance policies to raise cash. This is as much a turnaround play as a value play. That's something to keep in mind.

Remember SPU? Great Short Setups

Almost 3 years ago I put out Sky People Fruit Juice SPU as a net current asset stock. In about a week it has shot from $2 to $14 a share. No doubt a major short squeeze is going on and just pure momo. It has now become a great short. Another great short is KONE. Both of these will be significantly lower in a week. OPTT is another candidate when it finally loses momentum. Below are the charts of SPU and KONE.

MSN and JVA Revisited

I quickly went through a net current asset stock screen. There is not much out there to no surprise. There are a few though that have potential. I've been blogging on them some. The SORL, the SPU. I've blogged about these two deep value stocks a lot in the past. First up is Emerson Radio (MSN)and it has always been around net current asset value and profitable. I took a look at Emerson again and this is what I see currently. I see cash on the balance sheet stable the past year. It is actually marginally up from last year. Cash is 28.1 million. There is zero long-term debt. Total liabilities are just 3.9 million. So net cash is roughly $24 million. The market capitalization of the company is $27 million. So it is right around net cash with the stock at 1.01 per share. I don't think it is any coincidence the stock has bottomed out and found support around 1.00 the past couple years. You can see that here in this chart below.

They squeaked out a small profit last quarter though revenue doesn't look good. Who knows what is to come. I am going to put a limit order to buy some shares around 1.11 or lower. If the price drops below .90 the thesis doesn't work anymore and I'll take the loss.

Coffee Holding JVA is very close to being a net current asset stock. It's been a net tangible asset value stock for awhile. The price has just been in free fall this year. It appears technically it could be bottoming. I hope it keeps dropping though. I see this as the best net current asset value if we get there. It almost got there in early October this year in the 3.80s. That was the bottom though and it got picked up on strong buy volume. This one really just needs an activist investor I think. Something like that. I don't know a whole lot about this company but wholesale coffee can be consistently profitable.

Net Net SORL Is Cheap

I've made a couple posts on SORL Auto Parts over the past couple of years. Nothing has changed much with the companies long-term fundamentals. The only thing that has changed significantly is the stock price. It's net current asset value has actually increased from 2013 when it was $124 million and 2014's of $129 million. Right now $141.7 is the net current asset value of SORL. It still sells brakes and auto parts in China. It's a major player in commercial brakes. What I didn't realize about SORL before is how diversified it is internationally. 73% of its business is in China but 27% is international in 104 countries including the United States, UAE and Europe. I'm always skeptical of Chinese companies so I looked around to see if I could find info on where they are sold in the US. I didn't see anything which likely is because they are sold directly wholesale to big companies with commercial trucks. I did find some parts on Alibaba.

The stock is cheaper relative to NCAV than in 2013 with the market cap back at $50 million, NCAV at $141 million and the stock at 2.72. It is priced at 36% of net current asset value. I do believe this would even meet Benjamin Graham's margin of safety requirement! Sales have grown steadily every year since atleast as far back as 2012. Yet the current price to sales multiple is .23. Below 1 is low for about any decent company. The company is profitable yet the PE ratio is 3. On the balance sheet the current ratio is 3.6. Healthy. A cool $18 million in free cash flow in 2014.

I'm very bullish on China over the long-term and I would expect this correction currently going on in the overall China market to end sooner than later. The current PE multiple on the stocks in FXI is around 10-11. If you can get major Chinese companies for single digit PE's that is cheap. Not to mention some dividend yield too. SORL has a lot of support until 2.50. I think the fundamentals make it a compelling buy here.

Deep Value Stock Blonder Tongue BDR

You guys remember the value stock Blonder Tongue (BDR) ? It's usually been around net tangible asset value over the years. It will run up a bit one year then come back to around net tangibles. Well the stock has recently just crashed. It plummeted from over $2.00 a share to just $.77 a share. I went through the press releases on Yahoo! from the 30th and 31st on the day it crashed and couldn't find a good cause of the crash. They released quarterly results which were not to bad, not to good. I don't get it. There may be no good reason though of course and the stock is just crazy cheap for no reason. Here are the old posts on BDR. Looking back at all my notes on the stock $1.00 has been the floor for many years. At the last print it traded at $.90 Monday. This puts it at a market cap of roughly $5 million. Net current asset value is just above $5 million also. We are near net current asset value territory. I really like the stock here below $1 and might take a small position in it.

Bottom Up and Top Down Stocks

I went through some scans I typically go through and thought I'd post some that caught my eye. The first one bottom up is Sucampo Pharmaceuticals SCMP.  The chart was cool because it just broke out of consolidation on very strong volume. It's also at a 5 year high. I looked at it some more and this is just under a $700 million dollar company with a diverse portfolio of pharmaceuticals it sells. The good thing I see here is the earnings revisions. Next quarters earnings estimate is $.11 up from $.05 90 days ago. The current years estimate is $.47 a share up from $.22 ninety days ago. Next years EPS is currently $.60 up from $.40 ninety days ago. It's always great when earnings are revised up. With the stock at $15.66 this gives us a forward P/E multiple of 26. With earnings growing about the same rate the stock is conservatively fairly valued. However, the next 5 years are expected to grow more giving the stock a mere .35 PEG multiple(price to earnings growth). Lots of bullish stuff going on here.


SCMR New high on volume

 

 I found this coffee company called Coffee Holding Company ticker JVA. It is a small company with a mere $34 million dollar market cap. Coffee companies are usually good businesses especially if you are selling beans wholesale, which they are. They are profitable and I see no reason the stock should trade around net tangible asset value. Roughly $20 million is net tangible asset value and the market cap is just above it at $34. It's around technical support and just had a wide ranging day up 7%.

that is technical and fundamental support

The top down one is oil. I think it is a good time to start scaling into crude oil long. Everybody knows the ETF USO. USO is a terrible way to invest in oil. It's because of the way it rolls the contracts. It has to turnover futures contracts thus resulting in a lot of decay. The futures themselves CL is ideally the best way to trade oil. There are better ETF's like 12 month Oil ETF USL . USL holds longer term contracts and thus more closely resembles the actual price of oil. I'm long some USL now. Full Disclosure: long USL

The Best Net Net Stocks?

I looked through a lot of net-net's lately and didn't find all that much. On Zacks.com I screened for ones with zero long term debt. That diminished the universe of them along with ignoring all Chinese ADR's. So far this company called The LGL Group ticker LGL founded in the year 1917 seemed the most intriguing. Mostly because the company and stock price has not always struggled. The stock preformed very well in 2010.The company has $9.9 million in net current asset value and a market cap of just $8 mil. $5.4 mil of the net current asset value is cash. The company is not profitable. The last year of profitability was 2011. I put it sort of in the category of Emerson Radio MSN a perennial net because they are both electronics companies. MSN by the way is now selling for less than half of its net current asset value and is profitable.

Net-Net PRLS Update and Metals Setup

I've been writing on Peerless PRLS here on the blog for years and in the last post on it I called it one of the most compelling net current asset stocks out there. They recently made an acquisition and now have a cash buyout offer for $7.00 a share. I talked on the phone with Peerless PRLS Chairman and CEO Timothy Brog five years ago. He's been very committed and patient in adding shareholder value with this company.

Metals are on trend support. I have a buy stop order in too long JNUG at 21.80.  Crude oil has a setup as well. There is a triangular consolidation on this flag/pennant over the last few days. If crude continues to crash I have a buy stop order at 74 in to short oil with the ultrashort ETF SCO.